The Journal of Exercise & Organ Cross Talk (JEOCT) is an international, peer-reviewed, open-access journal dedicated to publishing high-quality research in molecular and cellular exercise physiology, with a particular focus on exercise-induced secretome, inter-organ communication, and the role of exercise in health and chronic-degenerative diseases. The journal welcomes original research articles, systematic reviews, meta-analyses, short communications, and translational studies that advance scientific understanding of human physiological adaptation to exercise.
JEOCT is a fully open-access journal. All articles are freely available online immediately upon publication without any subscription or paywall barriers. The journal operates under the principles of Open Science to ensure global dissemination of knowledge.
Authors retain full copyright over their work. All published articles are licensed under the Creative Commons Attribution-NoDerivatives 4.0 International (CC BY-ND 4.0), which permits sharing and adaptation for non-commercial purposes, provided proper credit is given to the original authors and the journal.
JEOCT does not charge any submission, processing, or publication fees. All costs associated with editorial handling are fully covered by Publisher.
JEOCT uses a rigorous double-blind peer-review system:
All submissions undergo initial screening with iThenticate plagiarism detection software. Manuscripts containing plagiarism, duplicate publication, or inappropriate text recycling are rejected before peer review. Serious cases may lead to institutional notification in line with COPE guidelines.
JEOCT adheres to the ethical principles outlined by the Committee on Publication Ethics (COPE) and follows established international standards. The journal’s full Publication Ethics and Malpractice Statement is available on the website (https://www.jeoct.com/journal/process?ethics).
To ensure long-term preservation of scholarly content, JEOCT employs:
JEOCT follows COPE guidance regarding generative AI:
JEOCT is fully sponsored by Vesnu Publications (Farzanegan Radandish), ensuring free and equitable access to scientific publishing.
The sponsor does not influence editorial decisions, peer-review processes, or journal governance.